Impartiality Statement

The AADC Research Trust is committed to achieving due impartiality in all it’s output. This commitment is fundamental to our reputation, our values and the trust of our audience. The term ‘due’ means that the impartiality must be adequate and appropriate to the output, taking account of the subject and nature of the content, the likely audience expectation and any signposting that may influence that expectation.

We endeavour to ensure that it is made clear to our audience when personal opinions or views are expressed.

The AADC Research Trust reports on information ascertained from various trusted sources.

Specifically at this time we are reporting - not advertising or promoting - on AAV2-hAADC Gene Replacement Therapy performed by Professor Krystof Bankiewicz in Poland. It is an ACTIVE treatment based on GT approach developed under NIH grant, approved by the FDA, 2 US IRB’s and constitute experimental treatment to save lives of AADC deficient children.

quick links

stay in touch

find us

  • Grey LinkedIn Icon
  • Grey Facebook Icon
  • Grey Twitter Icon
  • Grey YouTube Icon
  • Grey Instagram Icon


To contact us please email via: and we will endeavour to reply to you as soon as possible. We apologise in advance for any delays in our response, during this time. Our staff are on furlough and working from home. Please bear with us. Thank you for your patience.


The AADC Research Trust

Soper Hall, 2 Harestone Valley Road,

Caterham, Surrey, CR3 6HY

Registered Charity

UK & Wales No: 1114367

© AADC Research Trust